| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.27 | 0.06 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |